ORKAMBI
Live / Registered — Registered and renewed (as of 04 Aug 2025)
What this means for you
Registered since 29 Sept 2015. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 29 Sept 2025).
Record
- Serial number
- 86179790
- Registration number
- 4822946
- Mark type
- Stylized text
- Filed
- 30 Jan 2014
- Published for opposition
- 17 Jun 2014
- Registered
- 29 Sept 2015
- Next maintenance due
- 29 Sept 2025
- Attorney of record
- Lisa M. Tittemore
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cystic fibrosis
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 04 Aug 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 04 Aug 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 04 Aug 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 Aug 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Mar 2025 — TEAS SECTION 8 & 9 RECEIVED
- 29 Sept 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 23 Nov 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Nov 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Nov 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Aug 2021 — TEAS SECTION 8 & 15 RECEIVED
- 29 Sept 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Feb 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Sept 2015 — REGISTERED-PRINCIPAL REGISTER
- 28 Aug 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Aug 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED